CD4+ T cell subsets, such as Th1, Th2, Th17, and regulatory T (Treg) cells, serve pivotal functions in cancer immunity, among which the Th2 subset of CD4+ T cells secretes IL-4, IL-5, and IL-13, and activates B cells to become antibody-secreting plasma cells (49). The gene discussed is IL5; the disease is cancer.